Drug name…or Star Wars planet?
Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference.
02:04
Fri, Apr 10 20159:30 AM EDT
Similar Posts
We like the Mag 5 but are not fans of Apple or Tesla, says Cantor Fitzgerald’s Eric Johnston
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Eric Johnston, Cantor Fitzgerald head of equity derivatives and cross asset, joins ‘Closing Bell Overtime’ to talk the day’s market action and his investing playbook for 2024.
Three-Stock Lunch: Microsoft, KB Home and Bitcoin
Eva Ados, ER Shares CIO, joins ‘Power Lunch’ to discuss three stocks: Microsoft, KB Home and Bitcoin.
A point-of-sale system like Square on steroids
A New York City cowboy boot store may sell classic styles, but it’s been improving its sales by using technology and analytics on the Bindo POS iPad app.
Skylar Capital’s Bill Perkins calls Chesapeake & Southwestern possible merger ‘brilliant’
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bill Perkins, Skylar Capital founder, and CNBC’s Pippa Stevens join ‘Power Lunch’ to discuss a possible merger between Chesapeake and Southwestern and natural gas outlook. 03:42 Wed, Jan 10 20242:59 PM EST
Jim Cramer says investors should remember the optionality of 6 of the Magnificent 7
CNBC’s Jim Cramer keyed in on the optionality of six of the companies that have become known as the “Magnificent Seven” during his Wednesday show. “The Magnificent Seven have the most optionality of any publicly traded companies in modern history,” Cramer said. “To sell any of them is to forget that they have this kind…
Watch CNBC’s full interview with Oppenheimer’s Jason Helfstein
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jason Helfstein, Oppenheimer head of internet research, joins ‘Power Lunch’ to discuss positive expectations for Netflix’s earnings results, the cancelation reduction force of Netflix’s new ad tier, and Amazon’s adoption of live sports programming. 05:29 Tue, Oct 18 20222:56 PM EDT
